# Caris Life Sciences Inc. (CAI)

Source: https://www.quantisnow.com/company/CAI
Generated: 2026-11-15T17:15:05.621Z

- Ticker: CAI
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical Specialities
- IPO year: 2025
- SEC CIK: 0002019410
- Website: capps.com

## About

CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. It leases its container equipment to lessees under long-term, short-term, and finance leases. The company also sells containers; and manages equipment for to third-party investors, as well as sells used containers. As of December 31, 2020, it had a container fleet comprised 1,798,520 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California.

## Latest CAI news and filings

- 2026-11-05 18:14 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-caris-life-sciences-6775493)
- 2026-11-04 22:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-caris-life-sciences-inc-6773463)
- 2026-11-04 21:12 UTC [SEC Form 8-K] [Caris Life Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caris-life-sciences-inc-filed-sec-form-8-k-results-of-6772657)
- 2026-11-04 21:05 UTC [Earnings] [Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance](https://www.quantisnow.com/insight/caris-life-sciences-reports-third-quarter-2026-financial-results-and-6772322)
- 2026-10-19 10:30 UTC [Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection](https://www.quantisnow.com/insight/caris-life-sciences-launches-new-national-commercial-featuring-jordan-spieth-6750030)
- 2026-10-15 12:30 UTC [Earnings Date] [Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026](https://www.quantisnow.com/insight/caris-life-sciences-to-report-third-quarter-2026-financial-results-6747427)
- 2026-10-14 12:30 UTC [Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026](https://www.quantisnow.com/insight/caris-life-sciences-to-present-eight-studies-highlighting-the-power-6746031)
- 2026-09-23 21:06 UTC [SEC Form 4] [Officer Denton John Russel sold $238,626 worth of shares (7,500 units at $31.82), decreasing direct ownership by 4% to 174,855 units (SEC Form 4)](https://www.quantisnow.com/insight/officer-denton-john-russel-sold-238626-worth-of-shares-7500-6724435)
- 2026-09-17 22:08 UTC [SEC Form 4] [Officer Brille Brian J exercised 400,000 shares at a strike of $2.44 and sold $12,132,080 worth of shares (400,000 units at $30.33) (SEC Form 4)](https://www.quantisnow.com/insight/officer-brille-brian-j-exercised-400000-shares-at-a-strike-6719741)
- 2026-09-14 20:38 UTC [SEC Form 8-K] [Caris Life Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/caris-life-sciences-inc-filed-sec-form-8-k-regulation-fd-6714705)
- 2026-09-09 13:24 UTC [Analyst Coverage Initiated] [UBS initiated coverage on Caris Life Sciences with a new price target](https://www.quantisnow.com/insight/ubs-initiated-coverage-on-caris-life-sciences-with-a-new-6709646)
- 2026-09-08 10:30 UTC [Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect](https://www.quantisnow.com/insight/caris-life-sciences-launches-new-national-commercial-featuring-kevin-costner-6707308)
- 2026-09-02 12:30 UTC [Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer](https://www.quantisnow.com/insight/caris-life-sciences-to-present-new-research-advancing-precision-oncology-6702513)
- 2026-08-27 12:30 UTC [Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer](https://www.quantisnow.com/insight/caris-life-sciences-publishes-npj-precision-oncology-study-showing-ai-guided-6696551)
- 2026-08-24 20:29 UTC [SEC Form 144] [SEC Form 144 filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-caris-life-sciences-inc-6692852)
- 2026-08-14 21:44 UTC [SEC Form 4] [Director Castleman Peter M was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)](https://www.quantisnow.com/insight/director-castleman-peter-m-was-granted-13192-shares-increasing-direct-6683816)
- 2026-08-14 21:43 UTC [SEC Form 4] [Director Phillips T Danny was granted 13,192 shares, increasing direct ownership by 11% to 133,060 units (SEC Form 4)](https://www.quantisnow.com/insight/director-phillips-t-danny-was-granted-13192-shares-increasing-direct-6683813)
- 2026-08-14 21:42 UTC [SEC Form 4] [Director Minor Lloyd was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)](https://www.quantisnow.com/insight/director-minor-lloyd-was-granted-13192-shares-increasing-direct-ownership-6683810)
- 2026-08-14 21:41 UTC [SEC Form 4] [Director Gilliam Joseph E was granted 13,192 shares, increasing direct ownership by 82% to 29,321 units (SEC Form 4)](https://www.quantisnow.com/insight/director-gilliam-joseph-e-was-granted-13192-shares-increasing-direct-6683808)
- 2026-08-14 21:41 UTC [SEC Form 4] [Director Fredrickson David Paul was granted 13,192 shares, increasing direct ownership by 71% to 31,813 units (SEC Form 4)](https://www.quantisnow.com/insight/director-fredrickson-david-paul-was-granted-13192-shares-increasing-direct-6683806)
- 2026-08-14 21:40 UTC [SEC Form 4] [Director Vacirca Jeff L was granted 13,192 shares, increasing direct ownership by 27% to 62,863 units (SEC Form 4)](https://www.quantisnow.com/insight/director-vacirca-jeff-l-was-granted-13192-shares-increasing-direct-6683803)
- 2026-08-14 21:39 UTC [SEC Form 4] [Director Johansen Laura I was granted 13,192 shares, increasing direct ownership by 4% to 343,897 units (SEC Form 4)](https://www.quantisnow.com/insight/director-johansen-laura-i-was-granted-13192-shares-increasing-direct-6683802)
- 2026-08-14 21:38 UTC [SEC Form 4] [Director Halbert Jon was granted 13,192 shares, increasing direct ownership by 11% to 131,813 units (SEC Form 4)](https://www.quantisnow.com/insight/director-halbert-jon-was-granted-13192-shares-increasing-direct-ownership-6683800)
- 2026-08-12 16:38 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-caris-life-sciences-6677469)
- 2026-08-07 21:12 UTC [SEC Form 144] [SEC Form 144 filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-caris-life-sciences-inc-6672108)
- 2026-08-07 20:30 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-caris-life-sciences-6671811)
- 2026-08-05 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-caris-life-sciences-inc-6666158)
- 2026-08-05 20:12 UTC [SEC Form 8-K] [Caris Life Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/caris-life-sciences-inc-filed-sec-form-8-k-results-of-6665358)
- 2026-08-05 20:05 UTC [Public Offering] [Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance](https://www.quantisnow.com/insight/caris-life-sciences-reports-second-quarter-2026-financial-results-and-6665033)
- 2026-08-03 20:10 UTC [SEC Form 144] [SEC Form 144 filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-144-filed-by-caris-life-sciences-inc-6659759)
- 2026-07-16 12:30 UTC [Earnings Date] [Caris Life Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026](https://www.quantisnow.com/insight/caris-life-sciences-to-report-second-quarter-2026-financial-results-6639146)
- 2026-07-14 12:30 UTC [Caris Life Sciences Expands Precision Oncology in Metastatic Prostate Cancer with PTEN IHC Testing](https://www.quantisnow.com/insight/caris-life-sciences-expands-precision-oncology-in-metastatic-prostate-cancer-6636185)
- 2026-07-13 11:06 UTC [Insider Buy] [Director Halbert Jon bought $990,080 worth of shares (68,000 units at $14.56) (SEC Form 4)](https://www.quantisnow.com/insight/director-halbert-jon-bought-990080-worth-of-shares-68000-units-6634771)
- 2026-07-01 12:30 UTC [Caris Life Sciences Launches Caris Detect, the World's Most Sensitive and Comprehensive Multi-Cancer Early Detection Blood Test](https://www.quantisnow.com/insight/caris-life-sciences-launches-caris-detect-the-worlds-most-sensitive-6622055)
- 2026-06-16 15:09 UTC [SEC Form CERT filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-cert-filed-by-caris-life-sciences-inc-6604321)
- 2026-06-16 14:46 UTC [SEC Form 8-A12B filed by Caris Life Sciences Inc.](https://www.quantisnow.com/insight/sec-form-8-a12b-filed-by-caris-life-sciences-inc-6604307)
- 2026-06-16 12:30 UTC [Caris Life Sciences Announces Dual Listing on NYSE Texas](https://www.quantisnow.com/insight/caris-life-sciences-announces-dual-listing-on-nyse-texas-6604080)
- 2026-06-08 12:30 UTC [Caris Life Sciences Announces Share Repurchase Program](https://www.quantisnow.com/insight/caris-life-sciences-announces-share-repurchase-program-6592719)
- 2026-06-05 21:03 UTC [SEC Form 8-K] [Caris Life Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/caris-life-sciences-inc-filed-sec-form-8-k-submission-of-6591846)
- 2026-06-02 21:44 UTC [SEC Form 4] [Director Poste George was granted 1,600 shares, increasing direct ownership by 10% to 17,729 units (SEC Form 4)](https://www.quantisnow.com/insight/director-poste-george-was-granted-1600-shares-increasing-direct-ownership-6585090)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CAI
- Earnings history: https://www.quantisnow.com/earnings/CAI
- Dividend history: https://www.quantisnow.com/dividends/CAI
- Insider transactions: https://www.quantisnow.com/insiders/CAI
- Options chain: https://www.quantisnow.com/options/CAI
- SEC 8-K filings only: https://www.quantisnow.com/company/CAI/8-k
- RSS and alerts for CAI: https://www.quantisnow.com/docs/rss-feeds.md